These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6131655

  • 1. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV, Wyatt RJ.
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic measures in tardive dyskinesia].
    Tegeler J, Wöller W.
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [Abstract] [Full Text] [Related]

  • 3. Cholinergic treatments for tardive dyskinesia.
    Alphs LD, Davis JM.
    Mod Probl Pharmacopsychiatry; 1983 Jun; 21():168-86. PubMed ID: 6140629
    [No Abstract] [Full Text] [Related]

  • 4. Cholinergic influences in tardive dyskinesia.
    Tamminga CA, Smith RC, Ericksen SE, Chang S, Davis JM.
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA, McGrath JJ, Sailas E, Soares-Weiser K.
    Cochrane Database Syst Rev; 2002 Jul; (3):CD000207. PubMed ID: 12137608
    [Abstract] [Full Text] [Related]

  • 6. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    McGrath JJ, Soares KV.
    Cochrane Database Syst Rev; 2000 Jul; (2):CD000207. PubMed ID: 10796324
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of tardive dyskinesia.
    Casey DE, Denney D.
    Psychopharmacology (Berl); 1977 Aug 31; 54(1):1-8. PubMed ID: 410053
    [Abstract] [Full Text] [Related]

  • 8. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV, Wyatt RJ.
    Schizophr Bull; 1979 Aug 31; 5(2):251-93. PubMed ID: 37597
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K, Rathbone J.
    Cochrane Database Syst Rev; 2006 Jan 25; (1):CD000459. PubMed ID: 16437425
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ, Soares KV.
    Cochrane Database Syst Rev; 2000 Jan 25; (2):CD000459. PubMed ID: 10796546
    [Abstract] [Full Text] [Related]

  • 11. Managing tardive dyskinesia.
    Casey DE.
    J Clin Psychiatry; 1978 Oct 25; 39(10):748-53. PubMed ID: 30759
    [Abstract] [Full Text] [Related]

  • 12. The current status of tardive dyskinesia.
    Sachdev PS.
    Aust N Z J Psychiatry; 2000 Jun 25; 34(3):355-69. PubMed ID: 10881961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
    Morselli PL, Fournier V, Bossi L, Musch B.
    Psychopharmacology Suppl; 1985 Jun 25; 2():128-36. PubMed ID: 2860656
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
    Tammenmaa IA, Sailas E, McGrath JJ, Soares-Weiser K, Wahlbeck K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov 25; 28(7):1099-107. PubMed ID: 15610922
    [Abstract] [Full Text] [Related]

  • 18. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F, Henry E, Aimard G.
    Presse Med; 1986 Dec 06; 15(43):2147-50. PubMed ID: 2884657
    [Abstract] [Full Text] [Related]

  • 19. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares KV, McGrath JJ, Deeks JJ.
    Cochrane Database Syst Rev; 2000 Dec 06; (2):CD000203. PubMed ID: 10796320
    [Abstract] [Full Text] [Related]

  • 20. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D, Bralower M.
    Arch Neurol; 1977 Dec 06; 34(12):756-8. PubMed ID: 145212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.